Literature DB >> 10943691

Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?

E Koutsilieri1, S Czub, C Scheller, S Sopper, T Tatschner, C Stahl-Hennig, V ter Meulen, P Riederer.   

Abstract

HIV infection at late stages is associated with neurological complications including impaired motor and cognitive functions. We used simian immunodeficiency (SIV)-infected rhesus monkeys, an animal model of HIV infection, to investigate changes in choline acetyltransferase (ChAT) activity, a biochemical marker of cognitive function, in post-mortem brains during early, asymptomatic SIV infection and AIDS. ChAT activity was dramatically reduced in putamen and hippocampus already during asymptomatic infection. In animals with AIDS, ChAT activity was further decreased. The reduction of ChAT was not related to brain viral load or CNS pathological lesions. Our results demonstrate deficits in ChAT activity already during the first months of SIV infection and imply that cognitive dysfunction may occur early in immunodeficiency viral infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943691     DOI: 10.1097/00001756-200008030-00011

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.

Authors:  Yaxia Yuan; Xiaoqin Huang; Narasimha M Midde; Pamela M Quizon; Wei-Lun Sun; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2015-02-19       Impact factor: 4.418

Review 2.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

3.  Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.

Authors:  Gladys Chompre; Emmanuel Cruz; Lucianette Maldonado; Vanessa Rivera-Amill; James T Porter; Richard J Noel
Journal:  Neurobiol Dis       Date:  2012-08-25       Impact factor: 5.996

4.  Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.

Authors:  Charles Adeniran; Yaxia Yuan; Sarah E Davis; Ciai Lin; Jiahui Xu; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2021-04-22       Impact factor: 4.418

5.  Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

Authors:  Benjamin B Gelman; Joshua G Lisinicchia; Tianshen Chen; Kenneth M Johnson; Kristofer Jennings; Daniel H Freeman; Vicki M Soukup
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-06       Impact factor: 4.147

Review 6.  Molecular mechanisms of HIV-1 associated neurodegeneration.

Authors:  Hakan Ozdener
Journal:  J Biosci       Date:  2005-06       Impact factor: 2.795

7.  Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Authors:  Gaetano Perrotta; Guillaume Bonnier; Djalel-Eddine Meskaldji; David Romascano; Ruslan Aydarkhanov; Alessandro Daducci; Samanta Simioni; Matthias Cavassini; Melanie Metral; François Lazeyras; Reto Meuli; Gunnar Krueger; Renaud A Du Pasquier; Cristina Granziera
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

Review 8.  Nicotinic Acetylcholine Receptors in HIV: Possible Roles During HAND and Inflammation.

Authors:  Coral M Capó-Vélez; Manuel Delgado-Vélez; Carlos A Báez-Pagán; José A Lasalde-Dominicci
Journal:  Cell Mol Neurobiol       Date:  2018-07-14       Impact factor: 4.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.